Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership

Highlights • Despite predictions, the incidence of mesothelioma in the UK continues to rise. • A James Lind Alliance (JLA) Priority Setting Partnership (PSP) was established. • The PSP involved patients, carers, health professionals and support organisations. • The top 10 research priorities relatin...

Full description

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2015-08, Vol.89 (2), p.175-180
Main Authors: Stephens, R.J, Whiting, C, Cowan, K
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Humans
Interventions
James Lind Alliance
Lung Neoplasms - diagnosis
Lung Neoplasms - therapy
Mesothelioma
Mesothelioma - diagnosis
Mesothelioma - therapy
Mesothelioma, Malignant
Patient involvement
Priority Setting Partnership
Pulmonary/Respiratory
Research Priorities
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Despite predictions, the incidence of mesothelioma in the UK continues to rise. • A James Lind Alliance (JLA) Priority Setting Partnership (PSP) was established. • The PSP involved patients, carers, health professionals and support organisations. • The top 10 research priorities relating to mesothelioma patients were agreed. • These priorities highlight the most important issues for researchers and funders.
ISSN:0169-5002
1872-8332
DOI:10.1016/j.lungcan.2015.05.021